stockrowChina Pharma Holdings, Inc. (CPHI) vs Rockwell Medical, Inc. (RMTI)
- China Pharma Holdings, Inc. CPHI 0.56 +5.66%
- Rockwell Medical, Inc. RMTI 7.74 +1.84%
China Pharma Holdings, Inc. and Rockwell Medical, Inc. are both Drug Manufacturers Specialty & Generic companies. Rockwell Medical, Inc. is the larger, with a market value of $30.6M against $22.8M — 1.3× the size. China Pharma Holdings, Inc. grew revenue faster over the last twelve months: −11.0% against −21.1%. Rockwell Medical, Inc. has the higher net margin (−7.33% vs −114.3%) and the lower return on invested capital (−14.6% vs −7.23%). Across the 18 metrics below, Rockwell Medical, Inc. leads on 11 and China Pharma Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CPHI | RMTI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 11.76% | 17.71% | 53.51% |
| Operating margin | (111.84%) | (6.52%) | 0.00% |
| Net margin | (114.33%) | (7.33%) | (2.45%) |
| Free cash flow margin | (3.59%) | 2.47% | 0.00% |
| Return on equity | (20.99%) | (15.53%) | (0.80%) |
| Return on assets | (15.30%) | (9.32%) | (1.67%) |
| Return on invested capital | (7.23%) | (14.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack